# International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel

> **NCT02051868** · PHASE2 · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 80 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of the Anus

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** 5-Fluorouracil (5-FU)
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT02051868
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2017-08
- **Final completion:** 2018-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2015-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02051868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02051868, "International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02051868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*